Malignant Anorectal Neoplasm — Trials

Malignant Anorectal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,783 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 452
Recruiting: 249
Ph III recruiting: 38
Growth YoY: +8.5%
Industry share: 6%
Top sponsor: Fudan University
Termination share: 27.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (174)

clinicaltrialsPublishedShowing 51–100 of 575 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07104604	Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Tislelizumab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal Involvement	recruiting	Phase 2	51	Affiliated Cancer Hospital of Shantou University Medical CollegeOTHER	1	Jul 24, 2026	clinicaltrials
NCT04599140	SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial	active not recruiting	Phase 1 / Phase 2	51	M.D. Anderson Cancer Center